Historical position

Fisher Asset Management, LLC’s Bio Rad Labs Inc (BIO) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Fisher Asset Management, LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2021Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares150.26KHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Fisher Asset Management, LLC first reported Bio Rad Labs Inc in Q3 2021. The reported position was increased and reduced across later filings. Verified positive position history runs through Q1 2023. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2023
Sold 33.6% of the position−48.63K shares · 95.89K shares remained
Filing context

Quarter-end price $479.02

Q4 2022
Sold 2.4% of the position−3.60K shares · 144.52K shares remained
Filing context

Quarter-end price $0.42

Q3 2022
Sold 1.4% of the position−2.14K shares · 148.12K shares remained
Filing context

Quarter-end price $417.14

Q2 2022
Bought 7.3% more+10.26K shares · 150.26K shares reported after the change
Filing context

Quarter-end price $495.00

Q1 2022
Sold 0.02% of the position−24 shares · 140.00K shares remained
Filing context

Quarter-end price $563.23

Q4 2021
Sold 4.0% of the position−5.79K shares · 140.02K shares remained
Filing context

Quarter-end price $755.57

Portfolio importance

How important was Bio Rad Labs Inc in Fisher Asset Management, LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q1 2023
Last reported rank#258Rank unavailable
Peak portfolio weight0.1%Q3 2021
Best historical rank#160Q3 2021
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest filing quarter-end price$479.02Q1 2023

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-04
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Fisher Investments’ complete global portfolio, client mandates, short positions, exact trade dates or execution prices. Options are reported separately.